Viewing Study NCT03276468

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-01-03 @ 7:16 PM
Study NCT ID: NCT03276468
Status: COMPLETED
Last Update Posted: 2023-01-10
First Post: 2017-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas
Sponsor: The Lymphoma Academic Research Organisation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Follicular Lymphoma View
None Diffuse Large B Cell Lymphoma View
None Marginal Zone Lymphoma View
None Mucosa Associated Lymphoid Tissue View
Keywords:

Keywords

Keyword Brief Keyword Text View
None venetoclax; obinutuzumab; atezolizumab; lymphoma View